Literature DB >> 29556146

Effects of Older Donor Age and Cold Ischemic Time on Long-Term Outcomes of Heart Transplantation.

Heidi J Reich, Jon A Kobashigawa, Tamar Aintablian, Danny Ramzy, Michelle M Kittleson, Fardad Esmailian.   

Abstract

Using older donor hearts in cardiac transplantation may lead to inferior outcomes: older donors have more comorbidities that reduce graft quality, including coronary artery disease, hypertension, diabetes mellitus, and dyslipidemia. Shorter cold ischemic times might overcome the detrimental effect of older donor age. We examined the relationship between donor allograft age and cold ischemic time on the long-term outcomes of heart transplant recipients. rom 1994 through 2010, surgeons at our hospital performed 745 heart transplantations. We retrospectively classified these cases by donor ages of <50 years (younger) and ≥50 years (older), then by cold ischemic times of <120 min (short), 120 to 240 min (intermediate), and >240 min (long). Endpoints included recipient and graft survival, and freedom from cardiac allograft vasculopathy, nonfatal major adverse cardiac events, and rejection. For intermediate ischemic times, the 5-year recipient survival rate was lower when donors were older (70% vs 82.6%; P=0.02). This was also true for long ischemic times (69.8% vs 87.6%; P=0.09). For short ischemic times, we found no difference in 5-year recipient or graft survival rates (80% older vs 85.6% younger; P=0.79), in freedom from nonfatal major adverse cardiac events (83.3% vs 91.5%; P=0.46), or in freedom from cardiac allograft vasculopathy (50% vs 70.6%; P=0.66). Rejection rates were mostly similar. Long-term graft survival in heart transplantation patients with older donor allografts may improve when cold ischemic times are shorter.

Entities:  

Keywords:  Actuarial analysis; age factors; donor selection; graft survival; heart diseases/epidemiology/mortality; heart transplantation/methods/mortality; myocardial ischemia/surgery; retrospective studies; risk assessment/methods; survival rate; time factors; transplant recipients

Mesh:

Year:  2018        PMID: 29556146      PMCID: PMC5832079          DOI: 10.14503/THIJ-16-6178

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  18 in total

1.  The role of donor age and ischemic time on survival following orthotopic heart transplantation.

Authors:  D F Del Rizzo; A H Menkis; P W Pflugfelder; R J Novick; F N McKenzie; W D Boyd; W J Kostuk
Journal:  J Heart Lung Transplant       Date:  1999-04       Impact factor: 10.247

2.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report--2015; Focus Theme: Early Graft Failure.

Authors:  Lars H Lund; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Anne I Dipchand; Samuel Goldfarb; Bronwyn J Levvey; Bruno Meiser; Joseph W Rossano; Roger D Yusen; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2015-08-28       Impact factor: 10.247

3.  The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database.

Authors:  Mark J Russo; Jonathan M Chen; Robert A Sorabella; Timothy P Martens; Mauricio Garrido; Ryan R Davies; Isaac George; Faisal H Cheema; Ralph S Mosca; Seema Mital; Deborah D Ascheim; Michael Argenziano; Allan S Stewart; Mehmet C Oz; Yoshifumi Naka
Journal:  J Thorac Cardiovasc Surg       Date:  2007-02       Impact factor: 5.209

4.  Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999-2011.

Authors:  Harlan M Krumholz; Sharon-Lise T Normand; Yun Wang
Journal:  Circulation       Date:  2014-08-18       Impact factor: 29.690

Review 5.  Donor selection in heart transplantation.

Authors:  Ahmet Kilic; Sitaramesh Emani; Chittoor B Sai-Sudhakar; Robert S D Higgins; Bryan A Whitson
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

6.  Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation.

Authors:  Alykhan S Nagji; Tjasa Hranjec; Brian R Swenson; John A Kern; James D Bergin; David R Jones; Irving L Kron; Christine L Lau; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2010-07       Impact factor: 4.330

7.  Trends in heart failure incidence and survival in a community-based population.

Authors:  Véronique L Roger; Susan A Weston; Margaret M Redfield; Jens P Hellermann-Homan; Jill Killian; Barbara P Yawn; Steven J Jacobsen
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

8.  Effect of donor age on long-term survival following cardiac transplantation.

Authors:  Veli K Topkara; Faisal H Cheema; Satish Kesavaramanujam; Michelle L Mercando; Catherine S Forster; Michael Argenziano; Barry C Esrig; Mehmet C Oz; Yoshifumi Naka
Journal:  J Card Surg       Date:  2006 Mar-Apr       Impact factor: 1.620

9.  Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study).

Authors:  Patricia P Chang; Lloyd E Chambless; Eyal Shahar; Alain G Bertoni; Stuart D Russell; Hanyu Ni; Max He; Thomas H Mosley; Lynne E Wagenknecht; Tandaw E Samdarshi; Lisa M Wruck; Wayne D Rosamond
Journal:  Am J Cardiol       Date:  2013-11-09       Impact factor: 2.778

10.  Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis.

Authors:  Josef Stehlik; David S Feldman; Robert N Brown; Adrian B VanBakel; Stewart D Russel; Gregory A Ewald; Mary E Hagan; Jan Folsom; James K Kirklin
Journal:  J Heart Lung Transplant       Date:  2009-10-04       Impact factor: 10.247

View more
  2 in total

Review 1.  Heart Transplant Donor Selection Guidelines: Review and Recommendations.

Authors:  Shyama Sathianathan; Geetha Bhat
Journal:  Curr Cardiol Rep       Date:  2022-02-18       Impact factor: 2.931

2.  Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers.

Authors:  Martina Bona; Rahel K Wyss; Maria Arnold; Natalia Méndez-Carmona; Maria N Sanz; Dominik Günsch; Lucio Barile; Thierry P Carrel; Sarah L Longnus
Journal:  J Am Heart Assoc       Date:  2021-01-30       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.